Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1993-12-29
1995-05-23
Gerstl, Robert
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
548151, C07D51304, A61K 31425
Patent
active
054182484
ABSTRACT:
Compounds of the formula: ##STR1## in which R.sub.1 represents a hydroxy group, a C.sub.1 -C.sub.4 alkoxy group or an amino group of general formula --NR.sub.4 R.sub.5 in which R.sub.4 and R.sub.5 each represent, independently of each other, a hydrogen atom, a straight or branched C.sub.1 -C.sub.4 alkyl group, an allyl group or a methoxyethyl group, or alternatively --NR.sub.4 R.sub.5 represents a heterocycle containing 3 to 6 carbon atoms,
REFERENCES:
patent: 4896863 (1990-01-01), Hedgecock et al.
A. N. El Shorbagi et al., Chemical and Pharmaceutical Bulletin, vol. 36, No. 12, 1988, pp. 4760-4768.
George Pascal
Mangane Michel
Morel Claude
Sevrin Mireille
Gerstl Robert
Synthelabo
LandOfFree
2-thienylimidazo[2,1-.beta.]benzothiazole-3-acetic acid derivati does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with 2-thienylimidazo[2,1-.beta.]benzothiazole-3-acetic acid derivati, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and 2-thienylimidazo[2,1-.beta.]benzothiazole-3-acetic acid derivati will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2140701